NCT00017680
- Conditions
- Amyloidosis, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
- Locations
-
- Herbert Irving Comprehensive Cancer Center New York, United States
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
512 public trials
52 recruiting studies
Neoplasms, Plasma Cell trial results
NCT00001748
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +25 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
NCT00165347
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00358020
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Divisione Di Ematologia, Ospedale Centrale Bolzano, BOLZANO, Italy
- Unità Operativa Complessa Di Ematologia, Presidio Ospedaliero Dell'Annunziata, Azienda Ospedaliera Di Cosenza Cosenza, COSENZA, Italy
- Divisione Di Ematologia E Trapianto Di Midollo Osseo, Azienda Ospedaliera Cervello Palermo, PALERMO, Italy
- Divisione Di Ematologia, Ospedali Riuniti Reggio Calabria, Italy
Completed
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma
NCT00096837
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
Active, Not Recruiting
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
NCT04822337
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Levine Cancer Institute Charlotte, North Carolina, United States
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
Active, Not Recruiting
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)
NCT03162536
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
- Locations
-
- Mayo Clinic Hospital ( Site 0140) Scottsdale, Arizona, United States
- UCLA Hematology & Oncology ( Site 0017) Los Angeles, California, United States
- Colorado Blood Cancer Institute ( Site 0225) Denver, Colorado, United States
- University of Michigan ( Site 0018) Ann Arbor, Michigan, United States
Active, Not Recruiting
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
NCT00544115
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +95 more
- Locations
-
Not specified
Active, Not Recruiting
MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
NCT04649359
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beverly Hills Cancer Center Beverly Hills, California, United States
- Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UCLA Hematology/Oncology Clinic Los Angeles, California, United States
- UC Irvine Health - Chao Family Comprehensive Cancer Center Orange, California, United States
Active, Not Recruiting
Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
NCT00871013
- Conditions
- Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States